Royalty Pharma plc capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 1.30x
Net debt / equity: 1.22x
Debt / assets: 0.45x
Debt / EBITDA: 5.27x
Net debt / EBITDA: 4.93x

Liquidity & coverage

Current ratio: 2.66x
Quick ratio: 2.66x
Cash ratio: 1.14x
Interest coverage: 4.93x
EBITDA / interest: 5.05x
Working capital: $890.1M

Cash & dividend

FCF / debt: 0.30x
Cash flow / debt: 0.30x
Dividend per share: $0.91
Dividend yield: 1.6%
Dividend growth 1y: +4.8%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.